Feeds

Scientists brew up pure nerve stem cells

UK and Italian team hails breakthrough

Bridging the IT gap between rising business demands and ageing tools

Scientists at the University of Edinburgh have announced the successful creation - in conjunction with the University of Milan - of nerve stems cells, hailing the breakthrough as a great leap towards possible treatments for diseases such as Parkinson's and Alzheimer's.

The initial application for the cells will be to test the effectiveness of new medicines. Lead boffin professor Austin Smith told the BBC: "We're already talking with the bio-technology and bio-pharmaceutical companies about taking these cells into screening systems for new drugs. Hopefully that will come to pass within two to three years."

The long-term aim, however, is to use the cells for transplantation, although Smith admitted: "In terms of the possibility of using the cells for transplantation, that's a much more difficult and longer term thing and I think there we're talking more of the five to ten year range."

In creating the stem cells, the Edinburgh and Milan scientists overcame the tricky problem of not ending up with dish full of mixed stem and specialized cells. As the uni's blurb explains: "Until now, scientists had not been able to sustain the ability of neural stem cells to produce copies of themselves when grown in a dish. This meant that the population of cells in the dish would always become mixed, with only a few stem cells and many more specialized cells. By changing the growth conditions for the cells, the Edinburgh and Milan labs have for the first time established pure stem cell divisions, thus avoiding the unwanted differentiated cells."

Milan team member Luciano Conti concludes: "We applied techniques developed to control the behaviour of embryonic stem cells to our neural stem cells. The knowledge we already have about embryonic stem cells helped us to understand and control these more specialized stem cells." ®

Mobile application security vulnerability report

More from The Register

next story
Bad back? Show some spine and stop popping paracetamol
Study finds common pain-killer doesn't reduce pain or shorten recovery
Malaysian Airlines flight MH17 claimed lives of HIV/AIDS cure scientists
Researchers, advocates, health workers among those on shot-down plane
Mwa-ha-ha-ha! Eccentric billionaire Musk gets his PRIVATE SPACEPORT
In the Lone Star State, perhaps appropriately enough
SMELL YOU LATER, LOSERS – Dumbo tells rats, dogs... humans
Junk in the trunk? That's what people have
All those new '5G standards'? Here's the science they rely on
Radio professor tells us how wireless will get faster in the real world
The Sun took a day off last week and made NO sunspots
Someone needs to get that lazy star cooking again before things get cold around here
Boffins discuss AI space program at hush-hush IARPA confab
IBM, MIT, plenty of others invited to fill Uncle Sam's spy toolchest, but where's Google?
prev story

Whitepapers

Designing a Defense for Mobile Applications
Learn about the various considerations for defending mobile applications - from the application architecture itself to the myriad testing technologies.
How modern custom applications can spur business growth
Learn how to create, deploy and manage custom applications without consuming or expanding the need for scarce, expensive IT resources.
Reducing security risks from open source software
Follow a few strategies and your organization can gain the full benefits of open source and the cloud without compromising the security of your applications.
Boost IT visibility and business value
How building a great service catalog relieves pressure points and demonstrates the value of IT service management.
Consolidation: the foundation for IT and business transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.